Magnesium-dependent induction of Vibrio fischeri flagellar (Mif) biogenesis depends upon two diguanylate cyclases, suggesting an inhibitory role for cyclic di-GMP. Here, we report that cells defective for the sugar phosphotransferase system (PTS) exhibited a magnesium-independent phenotype similar to that of mutants of the Mif pathway. Unlike Mif mutants, PTS mutants also were hyperbioluminescent.
, which activates AC to synthesize cAMP. This cAMP binds cAMP receptor protein (CRP, also known as CAP), which then regulates the transcription of hundreds of genes, including flhDC, the master regulator of the Enterobacteriaceae flagellar regulon (for reviews, see references 6a, 10, 11, 17, and 30) .
Cyclic di-GMP (c-di-GMP) is a newly appreciated second messenger, apparently unique to bacteria, that modulates diverse cellular processes (for a recent review, see reference 21) . First identified as a positive effector of cellulose synthase in Gluconoacetobacter xylinus (reviewed in reference 22), c-di-GMP regulates transition from the motile, planktonic state to sessile, community-based behaviors, such as biofilm development. It tends to inhibit motility, both flagellar and twitching, while enhancing the biosynthesis of capsular components required by developing biofilms. c-di-GMP is synthesized by diguanylate cyclases (DGC) and degraded by phosphodiesterases (PDE) (21) . Together these activities maintain the steadystate concentration of c-di-GMP (22) . DGC activity has been associated with the highly conserved GGDEF domain. One PDE activity (to linear di-GMP) has been associated with the highly conserved EAL domain, while a second PDE activity (to two GMPs) has been associated with the HD-GYP domain (21) . Finally, a c-di-GMP-binding domain (termed PilZ) was recently reported (2) and shown to inhibit flagellar assembly in E. coli (25) .
Insights into the control of c-di-GMP production and its targets have come from our investigations of motility in the marine bacterium Vibrio fischeri. This bacterium, found as free-living, motile individuals or as a sessile community in association with the Hawaiian squid Euprymna scolopes, regulates the biogenesis of its flagella in response to the concentration of environmental magnesium (Mg 2ϩ ). In the presence of abundant Mg 2ϩ , such as that found in seawater, V. fischeri cells possess flagella; when Mg 2ϩ becomes limiting, they do not (14) . This Mg 2ϩ -dependent induction of flagellar (Mif) biogenesis depends upon at least two DGCs, one confirmed (MifA) and one putative (MifB) (Fig. 1) . Unlike wild-type (WT) cells, mutants that lack MifA or MifB or both synthesize flagellin proteins and become motile even when Mg 2ϩ is limiting (15) . Since MifA (and likely also MifB) catalyzes the production of c-di-GMP, these observations are consistent with a model in which c-di-GMP inhibits flagellar biogenesis, while Mg 2ϩ interferes with or overcomes that inhibition. Since overexpression of mifA did not exert a significant effect upon the transcription of flagellin genes, we have proposed that c-di-GMP acts posttranscriptionally (15) .
Disruption of both mifA and mifB under Mg 2ϩ -limiting conditions failed to promote the same level of migration that WT cells achieve in the presence of Mg 2ϩ ; this result suggests the existence of additional Mif pathway components. Therefore, during a recent study (15) , we searched for those additional components using a screen for transposon (Tn) mutants that migrated in the absence of Mg 2ϩ . The majority of the putative mutations mapped to mifA; however, several did not. Here, we report the characterization of one of the non-mifA mutants.
This non-mifA mutant (strain KV2657) exhibited a phenotype similar to those of mifA and mifB mutants: in the absence of Mg 2ϩ , like the mifA vector integration (Campbell) mutant (mifA::pKV217; strain KV2672) or the mifB Campbell mutant (mifB::pTMO125; strain KV2532), it migrated sooner and more rapidly than the positive control, KV1421 ( Fig. 2A and B) . In the presence of Mg 2ϩ , the migration rate of KV2657, like that of mutant mifA or mifB, was similar to that of the KV1421 control ( Fig. 2A and C) . Furthermore, even with Mg 2ϩ , the control strain left a dense mass of poorly motile and nonmotile cells at the site of inoculation. The Tn mutant, in contrast, did not, consistent with the hypothesis that a larger proportion of its cells became motile sooner than those of the control ( Fig. 2A and data not shown), a behavior reminiscent of mif mutants (15) .
Sequence analysis revealed that the Tn in strain KV2657 inserted (along with its delivery vector) into VF1896 (Fig. 3A) , an open reading frame (ORF) annotated to encode the Cterminal two-thirds of the PTS component EI; the N terminus of EI was annotated as VF1895 (23) . We hypothesized that the annotation of separate ORFs resulted from a sequencing error. We thus amplified, cloned, and sequenced the annotated junction of VF1895 and VF1896 and determined that VF1895/ VF1896 represents a single ORF (data not shown).
VF1895/VF1896 resides on chromosome 1 of V. fischeri, within a locus (VF1894 to -1897) (23) that bears a strong resemblance to the ptsHI-crr locus of E. coli K-12 (10, 24) . The proteins encoded by VF1894, VF1895/VF1896, and VF1897 share extensive identity, respectively, to those encoded by ptsH (HPr, 79%), ptsI (EI, 73%), and crr (EIIA Glc , 83%) (1, 27) . On the basis of this identity and the data presented below, we designated the VF1894 to -1897 locus as the V. fischeri ortholog of the E. coli ptsHI-crr operon. To test this designation, we constructed Campbell mutations in both the VF1895/VF1896 (ptsI::pTMO151) and the downstream VF1897 (crr::pTMO152) genes, verifying their construction by Southern blotting analysis. Although the resulting strains (KV2801 and KV2850, respectively) grew as well as their WT parent in rich medium, they grew poorly or not at all in minimal medium supplemented with several sugars, including glucose, glucosamine, and N-acetylglucosamine (data not shown).
To confirm the role of ptsI in Mg 2ϩ -dependent motility, we compared the migration behavior of strain KV2801 (the Campbell mutant) to that of strain KV2657, the original ptsI Tn insertion mutant (Fig. 2B) . The Campbell mutant exhibited a similar behavior: in the absence of Mg 2ϩ , it migrated sooner and faster than the control strain KV1421 ( Fig. 2A and B) ; in the presence of Mg 2ϩ , it behaved much like KV1421. Disruption of ptsI should preclude the phosphorylation of downstream components of the PTS pathways, including those specific for glucose, e.g., EIIA Glc (Fig. 1) . To determine whether 
EIIA
Glc also plays a role in controlling motility, we tested the crr Campbell mutant (strain KV2850): in the absence of Mg 2ϩ , it began migrating considerably sooner than its WT parent ( Fig. 2A and B) . In the presence of Mg 2ϩ , however, the crr mutant migrated quite a bit more slowly than either the WT or the mifA mutant ( Fig. 2A and C) . The reason for this behavior remains unknown but is unlikely to be due to differences in growth rate (data not shown).
The behavior of the ptsI mutant could be due either to an inability to phosphorylate downstream components or to a polar effect on the transcription of the downstream crr gene. In E. coli, the ptsHI-crr locus contains two minor promoters positioned upstream of crr within ptsI (10, 17, 26) . Thus, a polar mutation in the E. coli ptsI gene does not eliminate transcription from crr (17) . To determine whether this is also true of the V. fischeri ptsHI-crr locus, we performed reverse transcription (RT)-PCR (15) using primer pairs specific for ptsI and crr (Fig.  3A) . In contrast to the control cells (strain KV1421), which possessed transcripts for both ptsI and crr, the Tn insertion mutant (strain KV2657) showed a transcript for only crr (Fig.  3B ). These data demonstrate that the Tn insertion into ptsI does not exert polarity on the downstream crr. Thus, like its E. coli ortholog, the V. fischeri crr gene likely possesses its own promoter, and the effect of a ptsI deficiency likely results from an inability to phosphorylate EIIA Glc and/or other downstream components.
In E. coli, phospho-EIIA Glc activates flagellar biogenesis by enhancing AC activity. The resultant cAMP binds CRP, which activates transcription of flhDC, the operon that encodes the master activator of the E. coli flagellar regulon (11, 28) . In contrast, the data for V. fischeri (which uses a regulatory system that does not include flhDC) are consistent with a negative role for phospho-EIIA Glc , much like that for MifA, which appears to act subsequent to transcription (15) . To determine whether EI and/or EIIA Glc also act posttranscriptionally, we performed a semiquantitative RT-PCR analysis with flaA, flaC, and flaE, which encode major V. fischeri flagellins (12) , and with fliF, predicted to encode the M ring, whose insertion into the cytoplasmic membrane constitutes the first step in building flagella (19) . The cDNA levels were not substantially affected by the status of mifB (strain KV2825), ptsI (KV2801), or crr (KV2850) (data not shown). In contrast, the cDNA levels were substantially diminished but not eliminated by the disruption of rpoN (data not shown), which encodes 54 , proposed to sit near or at the top of the hierarchical V. fischeri flagellar regulon (strain KV1513) (19, 29) . We conclude that both the PTS and the Mif pathway impact flagellar biogenesis at similar levels.
Thus, we propose that phospho-EIIA Glc interacts with the Mif system to regulate flagellar biogenesis, most likely at a posttranscriptional level (Fig. 1) . This model is supported by the following observations: (i) ptsI and crr mutants of V. fischeri exhibited similar behavior, i.e., increased migration in the absence of Mg 2ϩ (Fig. 2) , suggesting that phospho-EIIA Glc is a prerequisite for the inhibition of flagellar biogenesis; (ii) disruption of either ptsI or crr exerted no significant effect upon the transcription of flagellin genes; and (iii) these behaviors resemble those of mif mutants (15) . We do not yet know how the Mif and PTS pathways interact, although we can imagine an interaction between phospho-EIIA Glc and the Mif pathway at any one of a number of levels ( Fig. 1 ): phospho-EIIA Glc could (i) activate a DGC; (ii) inhibit a PDE composed of an EAL domain and a nonconsensus "regulatory" GGDEF domain (21); (iii) interfere with the ability of c-di-GMP to interact with its target; or (iv) act independently. EIIA Glc , either in its phosphorylated or nonphosphorylated form, tends to interact with a variety of proteins, including not only EIICB Glc and AC (5a, 17) but also FrsA, which controls the fermentationrespiration switch (9) . Alternatively, the effect could be mediated by another PTS component, e.g., EI or HPr.
To further our understanding of the relationship between the PTS and the Mif pathway, we also considered the following published observations: (i) in E. coli, phospho-EIIA Glc activates AC to produce cAMP (6, 17, 20) ; (ii) cAMP binds and activates the transcriptional regulator CRP (30); and (iii) CRP of V. fischeri has been linked to the control of bioluminescence (J. L. Bose, U. Kim, W. Bartkowski, R. P. Gunsalus, A. M. Overley, K. L. Visick, and E. V. Stabb, submitted for publication; 7, 8, 13) . We therefore asked whether a mutation in mifA, mifB, ptsI, or crr impacted bioluminescence. We grew WT and mutant cells in a tryptone-based seawater medium (which contains Mg 2ϩ ) and measured bioluminescence over time. To account for any small differences in growth, we plotted the specific luminescence (relative light units/ml/optical density unit) versus optical density (Fig. 4) . Cells defective for mifA (KV2672) or mifB (KV2532) or both (KV2826) displayed bioluminescence patterns comparable to that of the WT strain (ES114). Surprisingly, however, mutants defective for either ptsI (KV2801) or crr (KV2850) exhibited substantially elevated levels of bioluminescence. Specifically, these mutations promoted an increase of over 300-fold in bioluminescence, allowing this naturally nonvisibly bioluminescent strain of V. fischeri to produce visibly detectable light. Given the clear differences in the bioluminescence patterns of these strains, these data support the conclusion that Mif and the PTS function in distinct pathways, at least with respect to bioluminescence.
At first glance, the observation that the PTS controls bioluminescence is not surprising: both cAMP and CRP have been 
